Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT Tablets
- Recalling company
- Preferred Pharmaceuticals, Inc.
- Product
- Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
- Reason
- Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Nov 17, 2025
- Reported
- Dec 24, 2025
- Distribution
- Natinowide in the USA
- Status
- Ongoing
- Quantity
- 575 1x10 Foil Blister Packs
- Lot / codes
- Lot: J1325J, I1725P, EXP Date: 4/30/2027.
- Company location
- Anaheim, CA
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0239-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0239-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.